Quadrivalent inactivated influenza vaccine (VaxigripTetra™)

• Main Authors: Viviane Gresset-Bourgeois (Author), Phillip S. Leventhal (Author), Stéphanie Pepin (Author), Rosalind Hollingsworth (Author), Marie-Pierre (Author), Iris De Bruijn (Author), Sandrine I. Samson (Author)
• Formato: Livro
• Publicado em: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Introduction: VaxigripTetra™ (IIV4; Sanofi Pasteur) is a quadrivalent split-virion influenza vaccine approved in Europe in 2016 for individuals ≥ 3 years of age. IIV4 builds on the well-established record of the trivalent split-virion influenza vaccine (Vaxigrip®). Areas covered: This literature rev...